The Biolocity Oversight Committee serves as both an advisory council and a decision-making board to select funded projects. The committee comprises clinical, industry, regulatory, investment, and entrepreneurial veterans with relevant technology and medical expertise and partner university technology transfer advisers.
Mary Albertson, CLP, RTTP
Director of Technology Licensing at Georgia Tech Research Corporation
Kirk Barnes, BA
Co-founder and President of Start-Up Commercialization and Sales Training of TransPharMed
Ibraheem Badejo, Ph.D.
Senior R&D Director, Ethicon External Front End Innovation at Johnson & Johnson
Mark Boden, Ph.D.
Senior Fellow/Technology Scout, Boston Scientific Corporation
Justin Burns, Ph.D.
Vice President, Innovation & Entrepreneurship, GRA
Monte Eaves, MD
Director, American Board of Plastic Surgery and Founder & CEO, Brijjit Co, LLC
Andrés J. García, Ph.D.
Executive Director, Parker H. Petit Institute for Bioengineering and Bioscience
Michelle Ho, Ph.D.
Senior Associate, 5AM Ventures
Derek Mazur, MSc
Private Company Investor, Cedar Pine
Rifat Pamukcu, MD
President & CEO, Midway Pharmaceuticals Inc.
Alyssa Panitch, Ph.D.
Professor and Chair of the Wallace H. Coulter Department of Biomedical Engineering
Shyam Parekh, Ph.D., MBA
Parekh Advisory Services
Jay Parrish, Ph.D.
Venture Partner, Arch Ventures
Preetha Ram, Ph.D.
Sr. Managing Partner, Pier 70
Todd Sherer, Ph.D.
Associate VP for Research Administration & Executive Director, Office of Technology Transfer, Emory University
Robert Taylor, MD
Professor of Medicine, Director, Division of Cardiology, Emory University School of Medicine
Robert Towarnicki, MS
Managing Partner, New Hope BioConsulting LLC and CEO, SIRPant Immunotherapeutics
David Wright, MD
Associate Professor and Director, Emergency Neurosciences at Emory University School of Medicine
Bob Yoder, MBA
Senior Vice President and Chief Business Officer, Trevena, Inc.